Joseph C Papa Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Joseph C Papa is of Candel Therapeutics, Inc.. Currently has a direct ownership of 38,032 shares of CADL, which is worth approximately $235,798. The most recent transaction as insider was on Dec 09, 2022, when has been sold 35,018 shares (Common Stock) at a price of $1.94 per share, resulting in proceeds of $67,934. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38K
0% 3M change
0% 12M change
Total Value Held $235,798

JOSEPH C PAPA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2022
BUY
Open market or private purchase
$67,934 $1.94 p/Share
35,018 Added 47.94%
38,032 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$5,123 $1.7 p/Share
3,014 Added 50.0%
3,014 Common Stock

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
Director
RXDX
Prometheus Biosciences, Inc. Healthcare
Director
BLCO
Bausch & Lomb Corp Healthcare
CEO & Chairman
EBS
Emergent BioSolutions Inc. Healthcare
President and CEO
JCP

Joseph C Papa

Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL